Showing results (71-80 of 203) with videos related to
Sort By:
Pageof 21
Chemico-Biological Interactions|March 30, 1995
Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cellsY Grosse, I Baudrimont, M Castegnaro, et al.Mutation Research|April 29, 1997
Evaluation of the genotoxic activity of metronidazole and dimetridazole in human lymphocytes by the comet assayJ L Ré, M P De Méo, M Laget, et al.Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 14, 2002
Implication of nitro group reduction in the mutagenic and chromosome damaging activities of 22 new 5-nitroisoquinolines by the Salmonella mutagenicity test and the cytokinesis-blocked micronucleus assayT Orsière, M De Méo, P Rathelot, et al.International Archives of Occupational and Environmental Health|January 1, 1997
Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalanS Hansel, M Castegnaro, M H Sportouch, et al.Psychopharmacology|April 16, 1998
In vivo apparent affinity and efficacy estimates for mu opiates in a rat tail-withdrawal assayE A Walker, G Zernig, A M YoungInternational Journal of Cancer|June 25, 1998
Sex- and strain-specific induction of renal tumors by ochratoxin A in rats correlates with DNA adductionM Castegnaro, U Mohr, A Pfohl-Leszkowicz, et al.Cancer Research|November 15, 1992
An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activityK Alexandrov, M Rojas, O Geneste, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedureE A Walker, G Zernig, J H WoodsThe Journal of the American Board of Family Practice|October 31, 1998
Understanding and caring for the distressed patient with multiple medically unexplained symptomsE A Walker, J Unützer, W J KatonJournal of Chromatography. B, Biomedical Sciences and Applications|January 19, 1999
Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposureM Castegnaro, L Garren, D Galendo, et al.Pageof 21